1 Ocak 2009 Dergi makalesi Açık Erişim

Pirkevi, C.; Lesage, S.; Condroyer, C.; Tomiyama, H.; Hattori, N.; Ertan, S.; Brice, A.; Basak, A. N.

Dublin Core

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Pirkevi, C.</dc:creator>
  <dc:creator>Lesage, S.</dc:creator>
  <dc:creator>Condroyer, C.</dc:creator>
  <dc:creator>Tomiyama, H.</dc:creator>
  <dc:creator>Hattori, N.</dc:creator>
  <dc:creator>Ertan, S.</dc:creator>
  <dc:creator>Brice, A.</dc:creator>
  <dc:creator>Basak, A. N.</dc:creator>
  <dc:date>2009-01-01</dc:date>
  <dc:description>The leucine-rich repeat kinase 2 (LRRK2) G2019S mutation is recognized as the most common cause of familial autosomal dominant and also sporadic forms of Parkinson disease (PD). A common founder has been described for most Europeans and all North Africans and Jews; besides, two distinct G2019S LRRK2 haplotypes were found in a small proportion of European families and in Japanese PD patients. This study revealed a Turkish patient heterozygous for the G2019S mutation sharing the Japanese haplotype. To the best of our knowledge, it is the first time that the G2019S-associated Japanese haplotype has been reported in a different population.</dc:description>
  <dc:identifier>https://aperta.ulakbim.gov.trrecord/40951</dc:identifier>
  <dc:identifier>oai:zenodo.org:40951</dc:identifier>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>http://www.opendefinition.org/licenses/cc-by</dc:rights>
  <dc:source>NEUROGENETICS 10(3) 271-273</dc:source>
  <dc:title>A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype</dc:title>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:type>publication-article</dc:type>
</oai_dc:dc>